Race-specific differences in influenza vaccination levels among Medicare beneficiaries--United States, 1993.
One national health objective for the year 2000 is to provide annual influenza vaccination to 60% of all noninstitutionalized, high-risk populations in the United States, (objective 20.11) (1). Since May 1, 1993, Medicare has reimbursed providers for the cost of influenza vaccine; reimbursement for the administration of the vaccine also has been provided for beneficiaries with part B coverage, which allows them to receive the vaccine without a copayment and without having to meet the annual deductible amount for part B reimbursement. Approximately 96% of all persons aged > or = 65 years in the United States have Medicare part B coverage (Health Care Financing Administration [HCFA], unpublished data, 1994). To characterize patterns of vaccine use by Medicare beneficiaries, HCFA and CDC estimated influenza vaccine use by Medicare beneficiaries during September-December 1993. Because of disparities in vaccine use by race, this analysis focused on race-specific differences between blacks and whites. This report presents the findings of that analysis.
D001741:Black or African American / Q000706:statistics & numerical data; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007252:Influenza Vaccines; D008297:Male; D006278:Medicare; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data*; D044465:White People / Q000706:statistics & numerical data
D007252:Influenza Vaccines